跳至主要内容
临床试验/NCT00795847
NCT00795847已完成4 期

The Efficacy and Safety of Losartan/Hydrochlorothiazide Combination Drug (Preminent) in Patients With Morning Hypertension

Kurume University1 个研究点 分布在 1 个国家目标入组 216 人开始时间: 2008年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
216
试验地点
1
主要终点
Blood pressure level in the morning by blood pressure self-measurement

研究概览

简要总结

It is difficult to control morning hypertension in practical clinical situation. Angiotensin receptor blocker (ARB) and thiazide are suggested to be effective to maintain the antihypertensive effects for 24 hours. However, monotherapy sometimes is not enough to control blood pressure level in the next morning and there are little evidence of the combination therapy for morning hypertension. The investigators hypothesized that a losartan 50 mg/hydrochlorothiazide 12.5 mg combination drug, Preminent, is effective and safe for controling morning hypertension, compared with high-dose of losartan 100 mg, in Japanese. Patients with morning hypertension were randomized to preminent treatment group or high-dose losartan treatment group. The efficacy and safety were compared after 3-month treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of outpatients with morning hypertension (135/85 mmHg)
  • Under treatment with any antihypertensive agents

排除标准

  • Poorly controlled hypertension (DBP>120 mmHg)
  • Poorly controlled diabetes (HbA1c>9.0%
  • Gout or hyperuricemia (UA>8.0 mg/dL)
  • Serum Cr>2.0 mg/dL
  • Serum K>5.5 mmol/L
  • Liver dysfunction (ALT>90 IU/L and/or g-GTP>14o IU/L)
  • Secondary hypertension
  • Patients who have contraindication for losartan and/or thiazide diuretics

研究组 & 干预措施

1. Preminent

Experimental

Patients with blood pressure self-measurement-proven morning hypertension are treated with Preminent 1T qd for 3 months.

干预措施: Preminent (losartan/hydrochlorothiazide combination drug) (Drug)

2. High-dose losartan

Active Comparator

Patients with blood pressure self-measurement-proven morning hypertension are treated with losartan 100 mg qd for 3 months.

干预措施: Preminent (losartan/hydrochlorothiazide combination drug) (Drug)

结局指标

主要结局

Blood pressure level in the morning by blood pressure self-measurement

时间窗: 3 months

次要结局

  • Serum levels of potassium, BUN, Creatinine, Uric acid, and Brain natriuretic peptide(3 months)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验